This site is for US consumers.
This site is for US consumers.Prescribing info

Protect yourself against RSV with
mRESVIA by Moderna

mRESVIA is used to protect adults aged 60 or older against lower respiratory tract disease
caused by respiratory syncytial virus (RSV).

For Linda, it all started with a relentless cough. Then, it became hard for her to breathe. When Linda tested positive for RSV, she didn't know that the virus was more common in people her age. Hear Linda's story about how RSV impacted her life.

Why vaccinate?

RSV stands for respiratory syncytial (sin-SISH-uhl) virus, a highly contagious virus that can affect your lungs and breathing passages. RSV can often begin with mild cold- or flu-like symptoms like coughing, sneezing, or a decrease in appetite. For people aged 60 or older, an RSV infection could lead to more serious symptoms like difficulty breathing, high fever, or chest pain. Don’t let RSV get in the way of the good stuff in your life. Protect yourself with mRESVIA.

RSV and your health

Effective protection against RSV

mRESVIA is highly effective at preventing severe illness due to RSV in people aged 60 or older. In a large and diverse clinical trial with over 35,000 participants, mRESVIA was proven to protect adults aged 60 or older against RSV, regardless of preexisting conditions.*

The most common side effects associated with mRESVIA include:

  • injection-site pain
  • fatigue
  • headache
  • muscle or joint pain
  • underarm swelling or tenderness
  • chills
In the clinical study, most of the side effects resolved within 1 to 2 days.

Savings and coverage

mRESVIA is covered for nearly all patients aged 60 or older and is available for Medicare Part D patients at $0.†‡ Ask your doctor or pharmacist if mRESVIA is covered.

CDC Recommended

To protect against RSV, the CDC recommends vaccinating all adults who are:
  • Aged 60 or older with increased risk of severe RSV disease
  • Aged 75 years or older

Frequently asked questions

RSV stands for respiratory syncytial (sin-SISH-uhl) virus, a highly contagious virus that can affect your lungs and breathing passages.
RSV is not a new virus, but you may not have heard of it because it is often underdiagnosed in adults. RSV symptoms can be similar to cold and flu symptoms, so unless you get sick enough to go to the hospital with RSV, you are unlikely to be tested.
An analysis of adults aged 60 or older who were hospitalized with either RSV, influenza, or COVID-19 showed that those with RSV infection were more likely to receive supplemental oxygen and admission to the ICU compared to patients with COVID-19 or influenza. Fortunately, there are vaccines available for flu, COVID-19, and RSV.
RSV can have lasting consequences, which include worsened preexisting conditions, reduced productivity and/or activity level, weakened cognitive ability, limited independence, and increased length of stay in the hospital.
  • Wash hands often with soap and water for at least 20 seconds
  • Avoid close contact with others who are sick
  • Avoid touching the face, particularly eyes, nose, and mouth
  • Clean frequently touched surfaces (such as doorknobs)

Remember that vaccines are available and provide protection against RSV for adults aged 60 or older. Ask your doctor or pharmacist if vaccination with mRESVIA is right for you.

mRESVIA is a vaccine indicated for the prevention of lower respiratory tract disease and acute respiratory disease caused by respiratory syncytial virus (RSV) in adults aged 60 or older.

The most common side effects associated with mRESVIA include:

  • injection site pain
  • fatigue
  • headache
  • muscle or joint pain
  • underarm swelling or tenderness
  • chills

Overall, mRESVIA was well tolerated with side effects described as mostly mild or moderate. In the clinical study, most of the side effects resolved within 1 to 2 days.


Call your pharmacist or doctor if you experience any side effects that do not go away after receiving your RSV vaccination.

If you are aged 60 or older, you can get your mRESVIA vaccine at any time during the year, giving you the flexibility to choose a time that’s best for you.
You don't have to wait to get vaccinated with mRESVIA if you already got your flu or COVID-19 vaccine. mRESVIA is an RSV vaccine that can be given at any time of the year. Ask your pharmacist or doctor about including mRESVIA in your vaccination routine.

Resources

Information about mRESVIA when you need it

This guide will help you learn more about mRESVIA.


*These conditions included chronic respiratory or heart conditions, advanced liver or kidney diseases, or diabetes.

Coverage and cost may vary and are subject to change without notice. Reimbursement decisions are made by individual insurance plans.

Per the Inflation Reduction Act.

What is mRESVIA and Important Safety Information

What is mRESVIA® (Respiratory Syncytial Virus Vaccine)?

mRESVIA is a vaccine to protect you against lower respiratory tract disease caused by Respiratory Syncytial Virus (RSV).

mRESVIA is for people 60 years of age and older. Vaccination with mRESVIA may not protect all people who receive the vaccine.

mRESVIA does not contain RSV. mRESVIA cannot give you lower respiratory tract disease caused by RSV.

Important Safety Information

Who should not get mRESVIA?

You should not get mRESVIA if you had a severe allergic reaction to any ingredient in mRESVIA.

What should you tell your healthcare provider?

Tell your healthcare provider about all of your medical conditions, including if you:

  • Have any allergies
  • Had a severe allergic reaction after receiving a previous dose of any other vaccine
  • Have a fever
  • Have a bleeding disorder or are on a blood thinner
  • Are immunocompromised or are on a medicine that affects your immune system
  • Have received any other RSV vaccine
  • Have ever fainted in association with an injection
How is mRESVIA given?

mRESVIA is given as an injection into the muscle.

What are the risks of mRESVIA?

There is a very small chance that mRESVIA could cause a severe allergic reaction. A severe allergic reaction would usually occur within a few minutes to one hour after getting a dose of mRESVIA. For this reason, your healthcare provider may ask you to stay for a short time at the place where you received your vaccine. Signs of a severe allergic reaction may include:

  • Trouble breathing
  • Swelling of your face and throat
  • A fast heartbeat
  • A rash all over your body
  • Dizziness and weakness

Side effects that have been reported in clinical trials with mRESVIA include:

  • Injection-site reactions: pain, underarm swelling or tenderness in the same arm of the injection, swelling (hardness), and redness
  • Fatigue, headache, muscle pain, joint pain, chills, nausea or vomiting, fever and hives

These may not be all of the possible side effects of mRESVIA. Ask your healthcare provider about any side effects that concern you. You may report side effects to the Vaccine Adverse Event Reporting System (VAERS) at 1-800-822-7967 or www.vaers.hhs.gov.

Please click for mRESVIA Full Prescribing Information.

Helpful Links
Find a vaccination site
About Moderna
Connect with Us
Report a side effect:
Adverse Event Intake Portal
Terms and ConditionsPrivacy Statement

© 2024 Moderna US-RSV-2400013 09/2024